Replies to post #2091 on GTC Biotherapeutics (fka GTCB)

[DewDiligence]

>Looking over the Atryn references I saw no mention of the University of Texas work on acute inhalation injury.<

If you have an abstract on this, I’ll add it to the reference list. I wonder if this will turn out to be a dead end like the antithrombin cancer program that GTCB licensed to Genzyme Molecular Oncology (GZMO) several years ago.